LabGenomics Co. Ltd - Asset Resilience Ratio
LabGenomics Co. Ltd (084650) has an Asset Resilience Ratio of 19.24% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 084650 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2014–2024)
This chart shows how LabGenomics Co. Ltd's Asset Resilience Ratio has changed over time. See debt-free asset ratio of LabGenomics Co. Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down LabGenomics Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of LabGenomics Co. Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩50.91 Billion | 19.24% |
| Total Liquid Assets | ₩50.91 Billion | 19.24% |
Asset Resilience Insights
- Good Liquidity Position: LabGenomics Co. Ltd maintains a healthy 19.24% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
LabGenomics Co. Ltd Industry Peers by Asset Resilience Ratio
Compare LabGenomics Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
| No industry peers found with asset resilience data. | ||
Annual Asset Resilience Ratio for LabGenomics Co. Ltd (2014–2024)
The table below shows the annual Asset Resilience Ratio data for LabGenomics Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 9.08% | ₩26.85 Billion ≈ $18.20 Million |
₩295.66 Billion ≈ $200.37 Million |
-14.23pp |
| 2023-12-31 | 23.31% | ₩73.07 Billion ≈ $49.52 Million |
₩313.46 Billion ≈ $212.43 Million |
-31.30pp |
| 2022-12-31 | 54.61% | ₩136.87 Billion ≈ $92.76 Million |
₩250.65 Billion ≈ $169.86 Million |
+6.19pp |
| 2021-12-31 | 48.41% | ₩98.90 Billion ≈ $67.02 Million |
₩204.29 Billion ≈ $138.44 Million |
-0.13pp |
| 2020-12-31 | 48.54% | ₩53.09 Billion ≈ $35.97 Million |
₩109.36 Billion ≈ $74.11 Million |
+20.12pp |
| 2019-12-31 | 28.42% | ₩14.06 Billion ≈ $9.53 Million |
₩49.48 Billion ≈ $33.53 Million |
-1.97pp |
| 2018-12-31 | 30.39% | ₩14.31 Billion ≈ $9.70 Million |
₩47.09 Billion ≈ $31.92 Million |
+13.70pp |
| 2017-12-31 | 16.69% | ₩6.66 Billion ≈ $4.51 Million |
₩39.87 Billion ≈ $27.02 Million |
-10.50pp |
| 2016-12-31 | 27.20% | ₩11.75 Billion ≈ $7.96 Million |
₩43.21 Billion ≈ $29.28 Million |
+27.19pp |
| 2015-12-31 | 0.01% | ₩2.03 Million ≈ $1.37K |
₩31.69 Billion ≈ $21.47 Million |
-6.75pp |
| 2014-12-31 | 6.75% | ₩2.10 Billion ≈ $1.42 Million |
₩31.09 Billion ≈ $21.07 Million |
-- |
About LabGenomics Co. Ltd
LabGenomics Co., Ltd. engages in the research and development of biotechnology products in South Korea. It is also involved in the sale of diagnostic devices. The company was founded in 2002 and is based in Seongnam-si, South Korea.